Getinge Taps Stacy Beske as New Leader in Acute Care Therapies Division
On November 9, 2026, Getinge made a significant announcement that could shape the future of its Acute Care Therapies division. Stacy Beske has been appointed as the new President of Acute Care Therapies, joining a robust executive team led by President and CEO Mattias Perjos. Beske is set to officially step into her new role on December 1, 2026.
Stacy Beske's impressive resume includes her most recent position as Senior Vice President and Business Unit Leader for Image Guided Therapy Devices at Philips. With over 20 years of experience in the medtech industry, Beske has honed her expertise in areas such as diabetes, electrophysiology, diagnostics, and cardiovascular care. Her academic credentials are equally impressive, holding a Ph.D. in Cardiovascular Physiology. This combination of leadership experience and scientific knowledge positions her as a key asset to Getinge, especially as they focus on enhancing patient care outcomes through advanced therapies.
Mattias Perjos expressed optimism regarding Beske's ability to lead the Acute Care Therapies division. 'Stacy has a strong track record of leading intricate businesses and transformations,' he remarked. He highlighted her talent for building high-performing teams and translating strategic plans into tangible results. This experience will be invaluable as Getinge continues its commitment to progress within the Acute Care sector, building on previous achievements.
In her own words, Stacy Beske shared her enthusiasm for joining Getinge, stating, 'I am very excited to join Getinge and to be leading Acute Care Therapies. The business has a strong portfolio and a crucial role in helping healthcare professionals improve outcomes for patients.' Her ambition to leverage her expertise and collaborate closely with colleagues globally showcases her dedication to further innovation and business advancement in her new role.
Based at Getinge's office in Wayne, New Jersey, Beske succeeds Elin Frostehav, who is leaving the organization to pursue other opportunities after a successful transition period. This change in leadership highlights the dynamic environment within Getinge, as they continue to adapt and evolve in the rapidly growing medtech landscape.
Founded on the belief that access to the highest quality care is a fundamental right for every person and community, Getinge is committed to providing top-notch products and solutions to hospitals and life sciences institutions. Their offerings include a wide range of medical solutions designed to optimize clinical outcomes and streamline workflows in areas such as intensive care, cardiovascular procedures, and more. With approximately 12,000 employees and operations across more than 135 countries, Getinge's global presence marks it as a significant player in the healthcare industry.
As this new chapter unfolds with Stacy Beske at the helm, the future of Acute Care Therapies at Getinge appears promising. Her extensive background and strong leadership are likely to drive the organization toward innovative solutions that will enhance patient care even further.
Stacy Beske's impressive resume includes her most recent position as Senior Vice President and Business Unit Leader for Image Guided Therapy Devices at Philips. With over 20 years of experience in the medtech industry, Beske has honed her expertise in areas such as diabetes, electrophysiology, diagnostics, and cardiovascular care. Her academic credentials are equally impressive, holding a Ph.D. in Cardiovascular Physiology. This combination of leadership experience and scientific knowledge positions her as a key asset to Getinge, especially as they focus on enhancing patient care outcomes through advanced therapies.
Mattias Perjos expressed optimism regarding Beske's ability to lead the Acute Care Therapies division. 'Stacy has a strong track record of leading intricate businesses and transformations,' he remarked. He highlighted her talent for building high-performing teams and translating strategic plans into tangible results. This experience will be invaluable as Getinge continues its commitment to progress within the Acute Care sector, building on previous achievements.
In her own words, Stacy Beske shared her enthusiasm for joining Getinge, stating, 'I am very excited to join Getinge and to be leading Acute Care Therapies. The business has a strong portfolio and a crucial role in helping healthcare professionals improve outcomes for patients.' Her ambition to leverage her expertise and collaborate closely with colleagues globally showcases her dedication to further innovation and business advancement in her new role.
Based at Getinge's office in Wayne, New Jersey, Beske succeeds Elin Frostehav, who is leaving the organization to pursue other opportunities after a successful transition period. This change in leadership highlights the dynamic environment within Getinge, as they continue to adapt and evolve in the rapidly growing medtech landscape.
Founded on the belief that access to the highest quality care is a fundamental right for every person and community, Getinge is committed to providing top-notch products and solutions to hospitals and life sciences institutions. Their offerings include a wide range of medical solutions designed to optimize clinical outcomes and streamline workflows in areas such as intensive care, cardiovascular procedures, and more. With approximately 12,000 employees and operations across more than 135 countries, Getinge's global presence marks it as a significant player in the healthcare industry.
As this new chapter unfolds with Stacy Beske at the helm, the future of Acute Care Therapies at Getinge appears promising. Her extensive background and strong leadership are likely to drive the organization toward innovative solutions that will enhance patient care even further.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.